Regeneron Acquires Bankrupt 23andMe's Assets for $256 Million Amidst Potential Layoffs in San Francisco
Regeneron Pharmaceuticals is acquiring the assets of 23andMe for $256 million, excluding its Lemonaid Health business, as the company faces layoffs and office closure due to financial struggles and a past cyberattack.
Latest News
About 2 hours ago
End of an Era: San Francisco's One Market Restaurant to Close After 32 Years on Embarcadero
About 3 hours ago
Billie Eilish Expands World Tour with Back-to-Back Performances at San Francisco's Chase Center
About 6 hours ago
About 8 hours ago